
Sunstone Life Science Ventures is an independent European venture capital investment firm based in Copenhagen, focused on life science therapeutics innovations. The firm typically makes its initial investments in companies raising Series A/B rounds across the European life science sector.
58% of their portfolio is in Biotech & Life Sciences. They made 2 investments in the last 12 months. Average disclosed round size is $33.6M (across 9 rounds with reported amounts).
Portfolio
24
Fund Size
—
Top Stage
Series A
Last 12 Mo
2
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
43 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| Series A | — | Aug 2026 | |
| Series C | — | Oct 2025 | |
| RResalis | Series A | — | Jan 2024 |
| Series A | — | Jan 2024 | |
| Series A | — | Mar 2023 | |
| RResalis | Seed | — | Feb 2023 |
| Seed | — | Feb 2023 | |
| Series B | — | Dec 2022 | |
| Series A | — | Feb 2022 | |
| TTarged Biopharmaceuticals | Series A | — | Jan 2022 |
| Series A | — | Jan 2022 | |
| Series B | — | Jan 2021 | |
| SSynendos | Series A | — | Nov 2020 |
| SStipe Therapeutics | Series A | — | Oct 2019 |
| Series B | — | Jan 2019 | |
| Series C | — | Oct 2018 | |
| PPrexton Therapeutics | Series B | — | Feb 2017 |
| PPrexton | Series B | $29M | Feb 2017 |
| PPrexton Therapeutics | Series B | $31M | Jan 2017 |
| PPrexton | Series B | $31M | Jan 2017 |
| PPrexton Therapeutics | Series A | $10M | Jan 2015 |
| PPrexton | Series A | $10M | Jan 2015 |
| Series C | — | Oct 2013 | |
| OOpsona Therapeutics | Series C | — | Oct 2013 |
| Series C | — | Apr 2013 |
Page 1 of 2
Top Co-Investors
Ysios Capital9 shared
Sunstone Partners9 shared
Hadean Ventures7 shared
Forbion7 shared
Novartis Venture Fund7 shared
Fountain Healthcare Partners6 shared
Roche Venture Fund6 shared
Amgen Ventures6 shared
Innovestor5 shared
OrbiMed5 shared
Novo Capital5 shared
M Ventures5 shared
Fund+4 shared
INKEF Capital4 shared
Kurma Partners4 shared
Industrifonden4 shared
Wellington Management4 shared
Sunstone4 shared
Seroba Life Sciences4 shared
Omnes Capital4 shared
Last updated: 18 November 2026